{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:06:57Z","timestamp":1787022417835,"version":"build-2736575974"},"reference-count":30,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej20-0129","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T18:05:16Z","timestamp":1591725916000},"page":"997-1006","source":"Crossref","is-referenced-by-count":24,"title":["Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database"],"prefix":"10.1507","volume":"67","author":[{"given":"Keisuke","family":"Matsubayashi","sequence":"first","affiliation":[{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Melmed S (2006) Acromegaly. N Engl J Med 355: 2558\u20132573.","DOI":"10.1056\/NEJMra062453"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Pivonello R, Auriemma RS, Grasso LFS, Pivonello C, Simeoli C, et al. (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20: 46\u201362.","DOI":"10.1007\/s11102-017-0797-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, et al. (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72: 203\u2013208.","DOI":"10.1111\/j.1365-2265.2009.03626.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159: 89\u201395.","DOI":"10.1530\/EJE-08-0267"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS (2018) Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol 179: 59\u201371.","DOI":"10.1530\/EJE-18-0255"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Swearingen B, Barker FG, Katznelson L, Biller BMK, Grinspoon S, et al. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83: 3419\u20133426.","DOI":"10.1210\/jc.83.10.3419"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, et al. (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83: 3411\u20133418.","DOI":"10.1210\/jcem.83.10.5111"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Mestron A, Webb S, Astorga R, Benito P, Catala M, et al. (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151: 439\u2013446.","DOI":"10.1530\/eje.0.1510439"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, et al. (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Li\u00e8ge, Belgium. J Clin Endocrinol Metab 91: 4769\u20134775.","DOI":"10.1210\/jc.2006-1668"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Bex M, Abs R, T\u2019Sjoen G, Mockel J, Velkeniers B, et al. (2007) AcroBel \u2013 the Belgian registry on acromegaly: a survey of the \u2018real-life\u2019 outcome in 418 acromegalic subjects. Eur J Endocrinol 157: 399\u2013409.","DOI":"10.1530\/EJE-07-0358"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72: 377\u2013382.","DOI":"10.1111\/j.1365-2265.2009.03667.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Raappana A, Koivukangas J, Ebeling T, Piril\u00e4 T (2010) Incidence of pituitary adenomas in Northern Finland in 1992\u20132007. J Clin Endocrinol Metab 95: 4268\u20134275.","DOI":"10.1210\/jc.2010-0537"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gruppetta M, Mercieca C, Vassallo J (2013) Prevalence and incidence of pituitary adenomas: a population-based study in Malta. Pituitary 16: 545\u2013553.","DOI":"10.1007\/s11102-012-0454-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kwon O, Song YD, Kim SY, Lee EJ (2013) Nationwide survey of acromegaly in South Korea. Clin Endocrinol (Oxf) 78: 577\u2013585.","DOI":"10.1111\/cen.12020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Tj\u00f6rnstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, et al. (2014) The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011. Eur J Endocrinol 171: 519\u2013526.","DOI":"10.1530\/EJE-14-0144"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, et al. (2015) The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study. Eur J Endocrinol 173: 655\u2013664.","DOI":"10.1530\/EJE-15-0189"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA (2015) The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013. Pituitary 18: 803\u2013807.","DOI":"10.1007\/s11102-015-0655-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Placzek H, Xu Y, Mu Y, Begelman SM, Fisher M (2015) Clinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysis. J Manag Care Spec Pharm 21: 1106\u20131114.","DOI":"10.18553\/jmcp.2015.21.12.1106"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Broder MS, Chang E, Cherepanov D, Neary MP, Ludlam WH (2016) Incidence and prevalence of acromegaly in the United States: a claims-based analysis. Endocr Pract 22: 1327\u20131335.","DOI":"10.4158\/EP161397.OR"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Burton T, Le Nestour E, Neary M, Ludlam WH (2016) Incidence and prevalence of acromegaly in a large US health plan database. Pituitary 19: 262\u2013267.","DOI":"10.1007\/s11102-015-0701-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Dal J, Feldt-Rasmussen U, Andersen M, Kristensen L\u00d8, Laurberg P, et al. (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175: 181\u2013190.","DOI":"10.1530\/EJE-16-0117"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Portocarrero-Ortiz LA, Vergara-Lopez A, Vidrio-Velazquez M, Uribe-Diaz AM, Garc\u00eda-Dominguez A, et al. (2016) The mexican acromegaly registry: clinical and biochemical characteristics at diagnosis and therapeutic outcomes. J Clin Endocrinol Metab 101: 3997\u20134004.","DOI":"10.1210\/jc.2016-1937"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Gatto F, Trifir\u00f2 G, Lapi F, Cocchiara F, Campana C, et al. (2018) Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database. Endocrine 61: 533\u2013541.","DOI":"10.1007\/s12020-018-1630-4"},{"key":"24","unstructured":"24 Irie M (1993) An epidemiological study report of diencephalic hypophyseal dysfunction. Report of Japanese investigation committee 1993 for specific diseases, diencephalic hypophyseal dysfunction of the Ministry of Health and Welfare. 237\u2013322 (In Japanese)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, et al. (2014) Acromegaly: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 99: 3933\u20133951.","DOI":"10.1210\/jc.2014-2700"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Yasunaga H (2019) Real world data in Japan: Chapter I NDB. Ann Clin Epidemiol 1: 28\u201330.","DOI":"10.37737\/ace.1.2_28"},{"key":"27","unstructured":"27 Kubo S, Noda T, Myojin T, Nishioka Y, Higashino T, et al. (2018) National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB): outline and patient-matching technique. https:\/\/www.biorxiv.org\/content\/10.1101\/280008v2. Accessed February 23, 2020."},{"key":"28","unstructured":"28 Statistics Bureau. Population estimates. Available from: http:\/\/www.stat.go.jp\/data\/jinsui\/index.htm. Accessed February 23, 2020 (In Japanese)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Arima H (2019) Diagnosis and treatment of hypothalamic pituitary dysfunction. Folia Endocrinol Jpn 95 Suppl: 1\u201360. https:\/\/www.jstage.jst.go.jp\/article\/endocrine\/95\/S.May\/95_1\/_article\/-char\/ja\/ (In Japanese).","DOI":"10.1507\/endocrine.95.S.May_1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Lavrentaki A, Paluzzi A, Wass JAH, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20: 4\u20139.","DOI":"10.1007\/s11102-016-0754-x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/10\/67_EJ20-0129\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T23:31:12Z","timestamp":1604100672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/10\/67_EJ20-0129\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0129","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}